• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE
Click for more information
2.83% 51.5¢

RECCE PHARMACEUTICALS LTD - Charts / Financials

Market Cap $105.0M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE UPDATE HIGHLIGHTS KEY DEVELOPMENTS FOR UPSIDE
refresh Created with Sketch. REFRESH
Last update - 15.59pm 18/04/2024 (20 minute delay) ?
Day
Open 55.0¢   Day High 55.0¢   Day Low 50.0¢
Daily Volume 132721
Bids   Sellers
Number Price Volume   Number Price Volume
1 50.0¢ 50000   2 55.0¢ 29999

Directors & Senior Management

Mr. James Hamilton Bray Graham Chief Executive Officer, Managing Director, Executive Director
Mr. Justin Reynolds Chief Financial Officer
Ms. Michele Keryn Dilizia Chief Scientific Officer, Executive Director
Dr. Philip Sutton Vice President of Translational Sciences
Dr. Justin Ward Executive Director and Principal Quality Chemist
Mr. Daniel Astudillo Head of Marketing
Mr. Thomas Jarrett Operations Manager
Dr. John Prendergast Independent Non- Executive Chairman of the Board
Mr. Alistair McKeough Non-Executive Director
Dr. Alan William Dunton Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
51.5¢ 		Change
-0.015(2.83%) 		Mkt cap ! $105.0M
Open High Low Value Volume
55.0¢ 55.0¢ 50.0¢ $68.01K 132.7K

Buyers (Bids)

No. Vol. Price($)
1 50000 50.0¢
 

Sellers (Offers)

Price($) Vol. No.
55.0¢ 29999 2
View Market Depth
Last trade - 15.59pm 18/04/2024 (20 minute delay) ?
Last
51.5¢ 		  Change
-0.015 ( 3.74 %)
Open High Low Volume
53.0¢ 53.0¢ 50.0¢ 2093
Last updated 15.59pm 18/04/2024 ?

Top Stories

Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs

Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.